in 2004, bd agreed to pay out $100 million to settle allegations from competitor retractable technologies that it had engaged in anti-competitive behavior to prevent the distribution of retractable's syringes, which are designed to prevent needlestick injury. the lawsuit touched off a series of legal conflicts between the companies. retractable would accuse bd of patent infringement after bd released a retractable needle of its own. later retractable would claim bd was falsely advertising its own version retractable needs as being the “world’s sharpest needle”. the debate between the two companies was partially the basis for the 2011 movie "puncture".